These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 1554521)

  • 1. Long-term treatment of amyotrophic lateral sclerosis with phthalazinol.
    Majkowski J
    Adv Second Messenger Phosphoprotein Res; 1992; 25():409-16. PubMed ID: 1554521
    [No Abstract]   [Full Text] [Related]  

  • 2. Phthalazinol, thrombocytopenia, and amyotrophic lateral sclerosis.
    Engel WK; Brooks BR
    Arch Neurol; 1980 May; 37(5):320. PubMed ID: 7387457
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of amyotrophic lateral sclerosis with thyrotropin releasing hormone].
    Serratrice G; Desnuelle C; Crevat A; Guelton C; Meyer-Dutour A
    Rev Neurol (Paris); 1986; 142(2):133-9. PubMed ID: 3088700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preliminary clinical study on the treatment of amyotrophic lateral sclerosis with TRH].
    Formisano R; Antonini G; Bove R; Millefiorini M; Ruggieri S
    Clin Ter; 1986 Dec; 119(6):479-81. PubMed ID: 3102155
    [No Abstract]   [Full Text] [Related]  

  • 5. [Attempts at treatment of amyotrophic lateral sclerosis].
    Domzal T; Ilnicki S
    Wiad Lek; 1974 Jun; 27(11):955-7. PubMed ID: 4839886
    [No Abstract]   [Full Text] [Related]  

  • 6. A pilot trial with clenbuterol in amyotrophic lateral sclerosis.
    Sorarù G; Pegoraro E; Spinella P; Turra S; D'Ascenzo C; Baggio L; Mantovan MC; Vergani L; Angelini C
    Amyotroph Lateral Scler; 2006 Dec; 7(4):246-8. PubMed ID: 17127564
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic trials in amyotrophic lateral sclerosis.
    Olarte MR
    Adv Neurol; 1982; 36():555-7. PubMed ID: 6758531
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunocorrective treatment of amyotrophic lateral sclerosis].
    Lobzin VS; Orlov AB; Zvegintsova TN
    Sov Med; 1991; (1):70-1. PubMed ID: 1862391
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
    Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyotrophic lateral sclerosis: failure of transfer factor therapy.
    Jonas S; Wichter M; Spitler L
    Ann Neurol; 1979 Jul; 6(1):84. PubMed ID: 507764
    [No Abstract]   [Full Text] [Related]  

  • 11. Amyotrophic lateral sclerosis syndrome and hyperthyroidism: report of 4 patients.
    Chotmongkol V
    J Med Assoc Thai; 1999 Jun; 82(6):615-8. PubMed ID: 10443086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is pentoxifylline safe and effective in patients with amyotrophic lateral sclerosis?
    Lindhorst S; Cudkowicz M
    Nat Clin Pract Neurol; 2006 Jul; 2(7):364-5. PubMed ID: 16932586
    [No Abstract]   [Full Text] [Related]  

  • 13. Familial amyotrophic lateral sclerosis.
    Poser CM; Johnson M; Bunch LD
    Dis Nerv Syst; 1965 Nov; 26(11):697-702. PubMed ID: 5843014
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose dextromethorphan in amyotrophic lateral sclerosis: phase I safety and pharmacokinetic studies.
    Hollander D; Pradas J; Kaplan R; McLeod HL; Evans WE; Munsat TL
    Ann Neurol; 1994 Dec; 36(6):920-4. PubMed ID: 7998781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of senile dementia and cerebellar disorders with phthalazinol. Cyclic AMP-increasing agent, phthalazinol, in therapeutic trials in hitherto incurable morbid conditions (I).
    Shimamoto T; Murase H; Numano F
    Mech Ageing Dev; 1976; 5(4):241-50. PubMed ID: 183066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Anomaly in the neurotransmitter amino acids in amyotrophic lateral sclerosis: a therapeutic application].
    Blin O; Desnuelle C; Guelton C; Aubrespy G; Ardissonne JP; Crevat A; Pouget J; Serratrice G
    Rev Neurol (Paris); 1991; 147(5):392-4. PubMed ID: 1677212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacotherapy of amyotrophic lateral sclerosis].
    Jokelainen M
    Duodecim; 1997; 113(6):513-6. PubMed ID: 11370073
    [No Abstract]   [Full Text] [Related]  

  • 18. [Amyotrophic lateral sclerosis. Clinical evaluation and therapeutic response to ara-A].
    Chimpen Ruiz V; Sánchez Rodríguez A; García Legido A; Pascual González F; Fermoso García J; de Portugal Alvarez J
    Rev Clin Esp; 1984 May; 173(4):223-5. PubMed ID: 6484249
    [No Abstract]   [Full Text] [Related]  

  • 19. Amyotrophic lateral sclerosis: metabolism of central monoamines and treatment with L-dopa.
    Mendell JR; Chase TN; Engel WK
    Trans Am Neurol Assoc; 1971; 96():284-6. PubMed ID: 5159109
    [No Abstract]   [Full Text] [Related]  

  • 20. [Progress in the treatment of degenerative diseases of the nervous system. Selected problems].
    Zaleska B
    Neurol Neurochir Pol; 1980; 14(2):209-12. PubMed ID: 6446688
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.